Heron Therapeutics CEO Collard Acquires Nearly 14,000 Shares
Heron Therapeutics CEO Craig A. Collard has acquired nearly 14,000 shares, signaling confidence in the company amidst industry challenges.
Zapata Zuluaga reports new investment in Grupo Cibest fund
Nicolas Zapata Zuluaga reports a transaction involving units in the Grupo Cibest Equity Securities Fund, reflecting ongoing investment in Grupo Cibest S.A.
Hagen Jonathan Hirt Reports Stock Transactions with Erie Indemnity
Hagen Jonathan Hirt discloses stock transactions involving Erie Indemnity Co., revealing significant share ownership and family holdings.
Hinnen Mart Theodore William acquires 345 shares of Enerpac
Hinnen Mart Theodore William reports acquiring 345 shares of Enerpac Tool Group Corp, increasing his total holdings to 13,890 shares.
Hagen reports stock transactions for Erie Indemnity Co.
Thomas B. Hagen disclosed new stock transactions involving Erie Indemnity Co., revealing changes in ownership structures and trust arrangements.
TowerView LLC Acquires Additional Shares in Tejon Ranch Co.
TowerView LLC has acquired additional shares in Tejon Ranch Co., reflecting confidence in the real estate market. Details of the transaction are outlined in the recent SEC filing.
Correnti Salvatore Reports Share Transactions in Erie Indemnity
Correnti Salvatore disclosed share transactions in Erie Indemnity, highlighting the importance of transparency in the insurance industry.
Michelle White reports acquisition of convertible note
Michelle White has reported a significant acquisition of a convertible promissory note, valued at over $163,000, impacting her stake in Rainmaker Worldwide Inc.
Forbes Acquires Shares in Heron Therapeutics Amid Transactions
William P. Forbes, Chief Development Officer at Heron Therapeutics, reports stock acquisitions, signaling confidence in the company’s future.
Donald R. Fishback Reports Class A Common Share Changes
Donald R. Fishback reports changes in Class A Common shares for Moog Inc., indicating strategic shifts in ownership within the industrial machinery sector.
Duarte Ira Reports Stock Transactions as CFO of Heron Therapeutics
Duarte Ira, CFO of Heron Therapeutics, reports stock transactions in recent SEC filing, reflecting his ongoing commitment to the company.
CEO Martine Rothblatt Reports Major Stock Transactions
Martine Rothblatt, CEO of United Therapeutics, reports significant stock transactions, reflecting her ongoing involvement in the pharmaceutical industry.
Restrepo Echavarria reports equity securities fund transaction
Luis Fernando Restrepo Echavarria reports a transaction involving Grupo Cibest Equity Securities Fund units, indicating ongoing investment in Grupo Cibest S.A.
Toro Valencia acquires units in Grupo Cibest fund
Juan Esteban Toro Valencia reported acquiring 441.77 units in Grupo Cibest Equity Securities Fund, valued at approximately $9.88 each.
Gator Capital Management Acquires Additional Shares in U S Global
Gator Capital Management has acquired 2,886 shares of U S Global Investors, increasing its holdings to 1,124,479 shares, reflecting its investment strategy.
de Souza Monteiro reports share transactions for AXIA Energia
Ivan de Souza Monteiro disclosed transactions involving common and preferred shares of AXIA Energia S.A., marking significant movements in the company's capital structure.
MBX Biosciences grants stock options to director Radovich
MBX Biosciences has granted stock options to director Peter Radovich, emphasizing its strategy to incentivize key personnel in the pharmaceutical industry.
Mejia Cardona reports transaction in Grupo Cibest units
Andres Felipe Mejia Cardona reports a transaction involving Grupo Cibest Equity Securities Fund units, reflecting ongoing investment in the company.
Timothy Eriksen Acquires 12,700 Shares in Saker Aviation
Timothy Eriksen increases his stake in Saker Aviation Services, acquiring 12,700 shares, now holding over 185,000 shares total.
Ran Assaf Acquires 10,000 Shares in Manhattan Bridge Capital
Ran Assaf, President and CEO of Manhattan Bridge Capital, reports acquisition of 10,000 shares, signaling confidence in the company's future.